Data Points
Use the table below for descriptions of each of the data points entered into the Portal.
For information on how these data points correspond with HHS guidance, click here.
Section | Data Point | Data Upload Template | Data Description | Validation Rules |
---|---|---|---|---|
Therapeutics |
39a. Current inventory on hand (in courses) |
Column Header: on_hand_supply_ Therapeutic_A_courses
Acceptable Values: 0 - 10,000 |
Enter the number of therapeutic A courses currently in inventory. This field has been designated as Casirivimab/Indevimab and is required as of 1/8/2021. |
|
Therapeutics |
39b. Courses used in the last week |
Column Header: previous_week_ Therapeutic_A_courses_used
Acceptable Values: 0 - 5,000 |
Enter the number of therapeutic A courses used in the previous week (preferred week: Wednesday-Tuesday) in an inpatient, ED, overflow, or outpatient location such as an urgent care, infusion center, or outpatient clinic. This field has been designated as Casirivimab/Imdevimab and is required as of 1/8/2021.
See Appendix D for additional information on therapeutic reporting. |
|
Therapeutics |
40a. Current Inventory on hand (in courses) |
Column Header: on_hand_supply_ Therapeutic_C_courses
Acceptable Values: 0 - 10,000 |
Enter the number of therapeutic C courses currently in inventory. This field has been designated as Bamlanivimab/Etsevimab and is required as of 4/07/2021.
See Appendix D for additional information on therapeutic reporting. |
|
Therapeutics |
40b. Courses used in the last week |
Column Header: previous_week_ Therapeutic_C_courses_used
Acceptable Values: 0 - 5,000 |
Enter the number of therapeutic C courses used in the previous week (preferred week: Wednesday-Tuesday) in an inpatient, ED, overflow, or outpatient location such as an urgent care, infusion center, or outpatient clinic. This field has been designated as Bamlanivimab/Etsevimab and is required as of 4/07/2021.
See Appendix D for additional therapeutic reporting information. |
|
Therapeutics |
40c. Therapeutic D Courses on Hand |
Column Header: on_hand_supply_ Therapeutic_D_courses
Acceptable Values: 0 - 10,000 |
Enter the number of therapeutic D courses currently in inventory. This field has been designated as Sotrovimab and is required as of 1/19/2022. |
|
Therapeutics |
40d. Therapeutic D Courses Administered in Last Week |
Column Header: previous_week_ Therapeutic_D_courses_used
Acceptable Values: 0 - 5,000 |
Enter the number of therapeutic D courses used in the previous calendar week (preferred week Wednesday-Tuesday) in an inpatient, ED, overflow, or outpatient location such as an urgent care, infusion center, or outpatient clinic. This field has been designated as Sotrovimab and is required as of 1/19/2022.
See Appendix D for additional therapeutic reporting information. |
|
Federally Inactive |
39c. Current Inventory on hand (in courses) |
Column Header: on_hand_supply_ Therapeutic_B_courses
Acceptable Values: 0 - 10,000 |
Enter the number of therapeutic B courses currently in inventory. This field has been designated as Bamlanivimab and is mandatory as of 1/8/2021.Do NOT count Bamlanivimab vials/courses here that are part of the combination Bamlanivimab / Etesevimab product. |
|
Federally Inactive |
39d. Courses used in the last week |
Column Header: previous_week_ Therapeutic_B_courses_used
Acceptable Values: 0 |
Enter the number of therapeutic B courses used in the previous calendar week in an inpatient, ED, overflow, or outpatient location, such as an urgent care, infusion center, or outpatient clinic. This field has been designated as Bamlanivimab and is mandatory as of 1/8/2021. Do NOT enter Bamlanivimab vials/courses here that are part of the combination Bamlanivimab / Etesevimab product. |